Mary‐Carmen Amigo

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Development of a New International Antiphospholipid Syndrome Classification Criteria Phase I/II Report: Generation and Reduction of Candidate Criteria”.

Development of a New International Antiphospholipid Syndrome Classification Criteria Phase I/II Report: Generation and Reduction of Candidate Criteria

Arthritis Care & Research(2020)10.1002/acr.24520

N/A

0DataRank · unranked

91 citations

Stéphane Zuily, Yasaman Ahmadzadeh, Mary‐Carmen Amigo, Tadej Avčin, María Laura Bertolaccini +19 more

Development of the 2023 ACR / EULAR Antiphospholipid Syndrome Classification Criteria, Phase III ‐C Report: Assessment of Patient Scenarios (Derivation Cohort) and Refinement of Definitions

Arthritis Care & Research(2025)10.1002/acr.25599

N/A

0DataRank · unranked

1 citations

Stéphane Zuily, Deanna Jannat‐Khah, Mary‐Carmen Amigo, Danieli Andrade, Tadej Avčin +26 more